Biologic for Type 2 Diabetes May Offer More Glycemic Control, Weight Loss Than Insulin
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Bouts of intense exercise can lead to cardiorespiratory fitness and decreased risk for cardiovascular disease in patients with type 2 diabetes.
Even moderate weight loss before bariatric surgery significantly reduces the risk for mortality in the 30 days after the operation.
Although bariatric surgery can effectively treat obesity and related physical comorbidities in adolescents, mental health issues often persist in the years after the procedure.
The aims of the study were to discover efficacy of bariatric surgery for remission of diseases related to obesity, estimate metabolic changes over 5 years, and compare the outcomes of restrictive and gastric bypass surgeries.
Though time-restricted eating (TRE) has been previously shown to contribute to fatigue and increased hunger in rare cases, most people participating in TRE saw their hunger decrease over time and experienced increased energy levels after continuing with the diet.
Study results published in JAMA Surgery explored the association between healthcare expenditures in veterans with obesity who had and had not undergone bariatric surgery.
A considerable proportion of cancer cases in men and women are attributable to excess body weight, with variation in the proportion among states
We have data suggesting that patients with established coronary disease who have wide fluctuations in weight have a significantly higher risk for adverse cardiovascular outcomes.